Glipxen-M 500 Tablet is an oral antidiabetic medication manufactured by Beacon Pharmaceuticals Ltd., combining two active ingredients: Linagliptin (2.5 mg) and Metformin Hydrochloride (500 mg). This combination is indicated for the management of type 2 diabetes mellitus in adults, particularly when diet and exercise alone are insufficient to achieve adequate glycemic control.